🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety of different doses of speci...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center (Consent and follow-up only)
Start Date
2016-06
Trial ID
NCT02792114
Treatments Being Tested
The purpose of this Phase I study is to test the safety of different doses ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
Start Date
2015-05
Trial ID
NCT02414269
Treatments Being Tested
This is a single-arm, open-label, one center, dose escalation clinical stud...
Status
Unknown
Location
China Meitan General Hospital
Start Date
2016-08
Trial ID
NCT02930993
Treatments Being Tested
Participants will have a sample of their white blood cells, called T cells,...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2024-09-30
Trial ID
NCT06623396
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Recruiting
Location
Shanghai Mengchao Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT06249256
Treatments Being Tested
This is a study in which pancreatic cancer patients receive a immunotherapy...
Status
Unknown
Location
Nanjing First Hospital
Start Date
2018-07-11
Trial ID
NCT03638193
Treatments Being Tested
The third generation of CAR-T cells that target GPC3, Mesothelin, Claudin18...
Status
Recruiting
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2017-07-01
Trial ID
NCT03198052
Pancreatic cancer patients receive chimeric antigen receptor (CAR) T cells ...
Status
Unknown
Location
First Affiliated Hospital of Wenzhou Medical University
Start Date
2017-10-01
Trial ID
NCT03497819
Treatments Being Tested
Autologous T-cells engineered to express CARs targeting Mesothelin and Clau...
Status
Recruiting
Location
District One Hospital
Start Date
2025-04-29
Trial ID
NCT07066995
Treatments Being Tested
The purpose of this study is to determine recommended phase 2 dose(s) (RP2D...
Status
Completed
Location
Hosp Univ Vall D Hebron
Start Date
2024-02-09
Trial ID
NCT06255665
Treatments Being Tested